跳至主要内容
临床试验/NCT04865380
NCT04865380Unknown3 期

Does Tranexamic Acid Improve Visualization During Arthroscopic Rotator Cuff Repair: A Double Blinded, Randomized Control Trial

University of Saskatchewan1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年1月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
50
试验地点
1
主要终点
Arthroscopic Visualization Score

研究概览

简要总结

This clinical trial examines whether intravenous preoperative administration of tranexamic acid (TXA) before arthroscopic rotator cuff repair (ARCR) can improve arthroscopic visualization during the procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Surgeons are blinded to group allocation and all treatment is administered by the anesthesia care provider. Patients will not be informed of their allocation.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-100
  • Male and Female
  • Patient able to read and understand consent form
  • Non-traumatic, simple small or medium sized rotator cuff tear as defined by pre-operative MRI
  • Booked to operating room for elective rotator cuff repair
  • Beach chair positioning

排除标准

  • Patient refusal to participate
  • Massive rotator cuff tear
  • Acute traumatic rotator cuff tear
  • Known coagulopathy
  • Patients with a history or risk of thromboembolism
  • Known hypersensitivity to tranexamic acid
  • Patient unable to be off anti-coagulant medication for long enough to counter effects
  • Patient has a clinic systolic blood pressure > 150mmHg
  • Lateral positioning
  • Requirement or insistence by patient or anesthesiologist on regional block
  • Patients who have smoked nicotine products within the last year
  • The presence of other inflammatory conditions (calcific tendonitis, rheumatoid arthritis, etc.)
  • The presence of active thromboembolic disease, such as deep vein thrombosis, pulmonary embolism, and cerebral thrombosis
  • Patient has a seizure disorder
  • Patients on medications identified as having drug-drug interactions (hormonal contraceptive, hydrochlorothiazide, desmopressin, sulbactam-ampicilllin, carbazochrome, ranitidine, or nitroglycerine
  • Patient is pregnant
  • Patients with history of subarachnoid hemorrhage
  • Patients with renal insufficiency
  • Patients with acquired disturbances of color vision

研究组 & 干预措施

Intravenous Tranexamic Acid

Experimental

1g of Tranexamic Acid will be administered intravenously prior to the start of the operation.

干预措施: Tranexamic Acid 100 MG/ML (Drug)

结局指标

主要结局

Arthroscopic Visualization Score

时间窗: Surgeon will complete the visualization score immediately after the surgery is completed.

A visualization score from 1 to 6 assessed by the surgeon. 1. - Perfect visualization 2. - Mild difficulty that could easily be worked around 3. - Moderate difficulty that required modifications to the surgical plan 4. - Significant difficulty that added more than 10 minutes to the case 5. - Major difficulty that added more than 20 minutes to the case 6. - Difficulty that forced the stoppage of the case

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeremy Reed

Principle Investigator

University of Saskatchewan

研究点 (1)

Loading locations...

相似试验

Does Tranexamic Acid Improve Visualization During... | 临床试验